News

Dermagraft, which is manufactured and marketed by Advanced BioHealing (ABH), is a human derived dermal substitute approved by the FDA for the treatment of diabetic foot ulcers (DFU).

The SonaStar is used by Neuro and General Surgeons for quick and efficient removal of both hard and soft tumors while sparing most vessels. Apart from this, OsteoSculpt

The vaccine, which does not contain an adjuvant, induced robust hemagglutination inhibition (HAI) responses, which have been shown to be important for protection against influenza disease. Novavax’s virus-like

The company expects to use the proceeds from the financing to complete the submission of a new drug application to the FDA for its lead product candidate, Davanat,

In the Phase II study in treatment-naive patients infected with hepatitis C virus (HCV) genotype 4, 82% (n=17) and 100% (n=16) of patients receiving low and high doses

Synta has earned a total of $130 million in payments from GlaxoSmithKline (GSK) to date, including the $80 million upfront payment in 2007, $40 million for milestones achieved

“2008 was a pivotal year for us as we concluded a series of corporate development activities, including divesting the majority of our non-core assets, retiring our convertible debt,

There are currently no agreements that preclude the broad and lawful licensing of these products, the company said. According to the company, Manapol is a biologic raw material

Before joining Immersion, Mr Anderson served as vice president of software engineering at LeapFrog Enterprises. Mr Anderson holds a bachelor’s and a master’s degree in computer and information